CASP3 and Hepatic fibrosis: Consistently, another study suggested that NRG (40 mg/kg) not only inhibited PI3K/AKT and following mTOR pathway but also increased the number of caspase-3 positive cells in fibrotic areas, decreased pro-inflammatory factors and alleviated experimental liver fibrosis induced by TAA [124].